ELAVL1 (ELAV Like RNA Binding Protein 1), also known as HuR (Hu Antigen R), is a member of the ELAV (Embryonic Lethal Abnormal Vision) family of RNA-binding proteins. This gene encodes a widely expressed RNA-binding protein that plays critical roles in post-transcriptional gene regulation by binding to adenine-uridine-rich elements (AU-rich elements, AREs) in the 3' untranslated regions (UTRs) of target mRNAs[1]. Through these interactions, HuR stabilizes messenger RNAs, regulates their translation, influences alternative splicing, and controls mRNA localization within cells.
In the nervous system, ELAVL1 is particularly important for maintaining neuronal function, regulating synaptic plasticity, and responding to cellular stress. Dysregulation of HuR expression and function has been implicated in several neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS)[2]. The protein's ability to modulate the stability and translation of transcripts involved in key disease pathways makes it a significant player in neurodegeneration research.
The human ELAVL1 gene is located on chromosome 19p13.2 and spans approximately 6.5 kilobases. The gene consists of 10 exons that encode a protein of 326 amino acids with a molecular weight of approximately 36 kDa. The gene structure is conserved across mammals, with particular conservation in the RNA-binding domains.
ELAVL1/HuR contains three RNA-binding domains (RBDs), each of the HNP (huA/PNC) type:
Each RBD consists of approximately 90 amino acids arranged in a classical RNA recognition motif (RRM) fold. The C-terminal region also contains a hinge region that allows flexibility between the RBDs, enabling cooperative binding to target mRNAs.
HuR undergoes several post-translational modifications that regulate its activity:
HuR's primary function is to bind to AU-rich elements (AREs) in the 3' UTR of target mRNAs, protecting them from degradation by exonucleases[5]. This stabilization is crucial for the regulated expression of many genes involved in:
Beyond stabilization, HuR can either enhance or repress translation of target mRNAs depending on the context:
HuR exhibits nucleocytoplasmic shuttling, which is essential for its function:
ELAVL1 is highly expressed in neurons throughout the central and peripheral nervous systems:
High expression is observed in:
ELAVL1 is significantly implicated in AD pathophysiology through multiple mechanisms[9]:
Amyloid-beta metabolism:
Tau pathology:
Synaptic dysfunction:
In PD, ELAVL1 is involved in several disease mechanisms[14]:
Oxidative stress response:
Mitochondrial dysfunction:
ELAVL1 plays a significant role in ALS[2:1]:
RNA metabolism dysregulation:
Stress granule formation:
Motor neuron degeneration:
HuR is a key mediator of cellular stress responses:
HuR activity is regulated by several signaling pathways:
HuR interacts with other RNA-binding proteins:
HuR represents a promising therapeutic target for neurodegenerative diseases[18]:
HuR expression levels in cerebrospinal fluid or peripheral blood mononuclear cells may serve as:
Abdelmohsen K, Gorospe M. Posttranscriptional regulation of AU-rich element mRNAs by the ELAV-like protein HuR. Trends in Biochemical Sciences. 2008. ↩︎
Brenner GJ, Begolka WS, Patel J, et al. Dysregulated post-transcriptional response mediated by RNA-binding proteins in amyotrophic lateral sclerosis. Brain. 2015. ↩︎ ↩︎ ↩︎
Lee HY, Lee KO, Hwang DY, et al. Modulation of HuR by phosphorylation in neuronal stress responses. Cellular Signalling. 2020. ↩︎
Fan L, Liu J, Huang Y, et al. m6A modification of HuR mRNA modulates its function in stress response. RNA Biology. 2019. ↩︎
Kurosaki T, Maquat LE. Nonsense-mediated mRNA decay in eukaryotic cells. Methods in Enzymology. 2019. ↩︎
Chang J, Gholami A, Kandel J, et al. Neuronal HuR regulates amyloid-beta production via alternative polyadenylation of APP mRNA. Journal of Neuroscience. 2021. ↩︎ ↩︎ ↩︎
Zhang J, Liu Y, Chen L, et al. Stress granule formation and dynamics in neurodegenerative diseases. Cellular and Molecular Neurobiology. 2018. ↩︎
De SK, Chattopadhyay S, Acharya K, et al. HuR and circadian rhythm regulation in the suprachiasmatic nucleus. Neuroscience. 2021. ↩︎
Papadaki M, Klinck P, Brooks D, et al. Elevated HuR in Alzheimer's disease and its relationship to tau pathology. Acta Neuropathologica Communications. 2022. ↩︎ ↩︎
Wang W, Liu Y, Wang J, et al. HuR-mediated tau mRNA stability and translation in Alzheimer's disease. Molecular Neurobiology. 2019. ↩︎ ↩︎
Van Hoof D, Probst A, Krol J, et al. Alternative splicing of tau exon 6 regulated by HuR. Human Molecular Genetics. 2018. ↩︎
Kato Y, Miyake K, Nishijima H, et al. Loss of nuclear HuR leads to impaired synaptic plasticity in aging neurons. Neurobiology of Aging. 2018. ↩︎ ↩︎
Li L, Cheng J, Chen Y, et al. HuR stabilizes ATG5 protein to facilitate autophagy in neurodegeneration. Autophagy. 2020. ↩︎ ↩︎
Yang J, Wu Z, Huang Y, et al. RNA-binding protein HuR in Parkinson's disease: oxidative stress and mitochondrial dysfunction. Redox Biology. 2021. ↩︎ ↩︎
Srikantan S, Gorospe M. HuR in cell fate decisions. Trends in Cell Biology. 2012. ↩︎
Das S, Bhattacharya S, Datta A, et al. Elavl1 regulates TDP-43 aggregation in response to cellular stress. Neurobiology of Disease. 2019. ↩︎
Sakao K, Began M, Kurosaki M, et al. HuR promotes neuronal survival through BDNF mRNA stabilization. Cell Death & Disease. 2020. ↩︎
Choi H, Lee J, Kim S, et al. Therapeutic targeting of HuR in neurodegenerative diseases. Advanced Drug Delivery Reviews. 2021. ↩︎